Indivior Pharmaceuticals Balance Sheet
NASDAQ: INDVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Indivior Pharmaceuticals financial position
At the end of fiscal 2025, Indivior Pharmaceuticals reported total assets of $1.20 billion, down 8.7% from a year earlier against total liabilities of $1.30 billion. Shareholders' equity was negative at -$98.0 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $195.0 million in cash and equivalents against $319.0 million of debt, a net debt position of $124.0 million.
The current ratio (current assets divided by current liabilities) was 0.71, meaning short-term obligations exceed short-term assets.
Summary generated from market data by MetaCap's automated system. Methodology
Indivior Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 |
|---|---|---|---|---|---|
| Cash & Equivalents | 195.00M | 319.00M | 316.00M | 774.00M | 1.10B |
| Short-Term Investments | 0 | 1.00M | 94.00M | — | — |
| Receivables | 253.00M | 254.00M | 254.00M | — | — |
| Inventory | 153.00M | 167.00M | 126.00M | 114.00M | 95.00M |
| Total Current Assets | 652.00M | 827.00M | 1.26B | 1.26B | 1.44B |
| Property, Plant & Equipment | 144.00M | 100.00M | 84.00M | 54.00M | 58.00M |
| Goodwill | 2.00M | 2.00M | 5.00M | — | — |
| Long-Term Investments | 28.00M | 27.00M | 41.00M | — | — |
| Total Assets | 1.20B | 1.32B | 1.76B | 1.77B | 1.83B |
| Accounts Payable | 48.00M | 63.00M | 39.00M | 617.00M | 720.00M |
| Short-Term Debt | 29.00M | 18.00M | 6.00M | 3.00M | 3.00M |
| Total Current Liabilities | 914.00M | 924.00M | 1.28B | 1.02B | 804.00M |
| Long-Term Debt | 290.00M | 315.00M | 237.00M | 237.00M | 239.00M |
| Total Liabilities | 1.30B | 1.65B | 1.94B | 1.72B | 1.63B |
| Shareholders' Equity | -98.00M | -337.00M | -184.00M | -15.00M | 121.00M |
| Retained Earnings | -243.00M | -443.00M | -288.00M | 1.30B | 1.44B |
| Total Debt | 319.00M | 333.00M | 243.00M | 240.00M | 242.00M |
| Net Cash (Debt) | -124.00M | -13.00M | 167.00M | 534.00M | 860.00M |
This table shows 5 annual periods of Indivior Pharmaceuticals's balance sheet, from FY 2025 back to FY 2021, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow INDV's reporting calendar. What is a balance sheet?